{
    "eid": "2-s2.0-85095786606",
    "title": "The glutathione system in Parkinson's disease and its progression",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neuropsychology and Physiological Psychology",
            "@code": "3206",
            "@abbrev": "PSYC"
        },
        {
            "@_fa": "true",
            "$": "Cognitive Neuroscience",
            "@code": "2805",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Behavioral Neuroscience",
            "@code": "2802",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "(Neuro)inflammation",
        "Antioxidants",
        "Glutathione",
        "Neuro-Immune",
        "Oxidative stress",
        "Parkinson's disease"
    ],
    "authors": [
        "Geir Bj\u00f8rklund",
        "Massimiliano Peana",
        "Michael Maes",
        "Maryam Dadar",
        "Beatrice Severin"
    ],
    "citedby-count": 63,
    "ref-count": 140,
    "ref-list": [
        "Xenobiotics, trace metals and genetics in the pathogenesis of Tauopathies",
        "Gamma-glutamyltranspeptidase-dependent glutathione catabolism results in activation of NF-kB",
        "Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models",
        "Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion",
        "Do Alterations in Glutathione and Iron Levels Contribute to Pathology Associated with Parkinson's Disease? Ageing Vulnerability: Causes and Interventions",
        "Role of mitochondrial ROS in the brain: from physiology to neurodegeneration",
        "Impaired glutathione synthesis in neurodegeneration",
        "Regulation of neuronal glutathione synthesis",
        "Intranigral LPS administration produces dopamine, glutathione but not behavioral impairment in comparison to MPTP and 6-OHDA neurotoxin models of Parkinson's disease",
        "Glutathione degradation",
        "Induction of oxidative stress and DNA damage in rat brain by a folate/methyl-deficient diet",
        "Biliary secretion of glutathione and of glutathione-metal complexes",
        "Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system",
        "Differential effects of pro- and anti-inflammatory cytokines alone or in combinations on the metabolic profile of astrocytes",
        "Glutathione, glutaredoxins, and Iron",
        "Environmental toxicity, redox signaling and lung inflammation: the role of glutathione",
        "Redox modifications of protein\u2013thiols: emerging roles in cell signaling",
        "The role of xenobiotics and trace metals in parkinson's disease",
        "Metals and Parkinson's disease: mechanisms and biochemical processes",
        "Iron and other metals in the pathogenesis of Parkinson's disease: toxic effects and possible detoxification",
        "TNF and ROS crosstalk in inflammation",
        "Oxidative stress and Parkinson's disease",
        "Glutamate-evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte cultures",
        "The neuroprotective effect of dimethyl fumarate in an MPTP-mouse model of Parkinson's disease: involvement of reactive oxygen species/nuclear factor-\u03baB/nuclear transcription factor related to NF-E2",
        "Selective and persistent activation of extracellular signal-regulated protein kinase by nitric oxide in glial cells induces neuronal degeneration in glutathione-depleted midbrain cultures",
        "The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress",
        "S-Nitrosoglutathione and glutathione act as NMDA receptor agonists in cultured hippocampal neurons 1",
        "Investigating the role of glutathione in mismatch negativity: an insight into NMDA receptor disturbances in bipolar disorder",
        "A multi-biomarker analysis of the antioxidant efficacy of Parkinson's disease therapy",
        "Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: association with glutathione-S-transferase and DNA repair gene polymorphisms",
        "Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases",
        "Functional consequences of age-dependent changes in glutathione status in the brain",
        "Pyridoxine (Vitamin B6) and the glutathione peroxidase system; a link between one-carbon metabolism and antioxidation",
        "Role of extracellular signal-regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures",
        "The role of oxidative stress in Parkinson's disease",
        "Transient glutathione depletion in the substantia nigra compacta is associated with neuroinflammation in rats",
        "Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity",
        "Global, regional, and national burden of Parkinson's disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016",
        "Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF",
        "The fairytale of the GSSG/GSH redox potential",
        "Glutathione: overview of its protective roles, measurement, and biosynthesis",
        "The central role of glutathione in the pathophysiology of human diseases",
        "Oxidative post-translational modifications in histones",
        "Glutathione and cellular redox control in epigenetic regulation",
        "Role of glutathione in the regulation of epigenetic mechanisms in disease",
        "Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons",
        "Modulation of astrocytic metabolic phenotype by proinflammatory cytokines",
        "Multiple roles of glutathione in the central nervous system",
        "Glia: the fulcrum of brain diseases",
        "Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease",
        "Glutathione depletion: starting point of brain metabolic stress, neuroinflammation and cognitive impairment in rats",
        "Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects: alterations in the activities and protein expression of glutathione-related enzymes",
        "Glutathione redox imbalance in brain disorders",
        "l-\u03b3-Glutamyl-l-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro-and anti-inflammatory cytokines: a signaling transcriptional scenario for redox (y) immunologic sensor (s)?",
        "Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism",
        "N-acetylcysteine boosts brain and blood glutathione in gaucher and Parkinson's diseases",
        "Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?",
        "Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice",
        "Role of microglial redox balance in modulation of neuroinflammation",
        "Glutathione deficiency leads to mitochondrial damage in brain",
        "Glutathione and signal transduction in the mammalian CNS",
        "Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism",
        "Glutathione S-Transferase alpha 4 prevents dopamine neurodegeneration in a rat alpha-synuclein model of Parkinson's disease",
        "Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease",
        "Caffeoylquinic acid derivatives rich extract from Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia and acute gouty arthritis in animal model",
        "The roles of redox enzymes in Parkinson's disease: focus on glutaredoxin",
        "Extracellular redox state: refining the definition of oxidative stress in aging",
        "Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control",
        "Glutathione is a key player in metal-induced oxidative stress defenses",
        "Ceftriaxone attenuates glutamate-mediated neuro-inflammation and restores BDNF in MPTP model of Parkinson's disease in rats",
        "Neuroinflammation induces neurodegeneration",
        "Glutathione peroxidase activity in Parkinson's disease brain",
        "Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in parkinson's disease",
        "Biliary excretion of glutathione and glutathione disulfide in the rat. Regulation and response to oxidative stress",
        "Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases",
        "Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease",
        "Glutathione depletion activates mitogen-activated protein kinase (MAPK) pathways that display organ-specific responses and brain protection in mice",
        "The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1",
        "Glutathione S-transferase T1 and M1 null genotypes and Parkinson's disease risk: evidence from an updated meta-analysis",
        "Mitochondrial glutathione: features, regulation and role in disease",
        "Glutathione\u2014a review on its role and significance in Parkinson's disease",
        "Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation",
        "Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease",
        "Protection by pyruvate against glutamate neurotoxicity is mediated by astrocytes through a glutathione-dependent mechanism",
        "Oxidative stress in blood cells of men and women with Alzheimer's and Parkinson's diseases",
        "Identification of S-acyl glutathione conjugates of bile acids in human bile by means of LC/ESI-MS",
        "ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications",
        "Dopamine, oxidative stress and protein\u2013Quinone modifications in parkinson's and other neurodegenerative diseases",
        "The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes",
        "Nigral endothelial dysfunction, homocysteine, and Parkinson's disease",
        "Bisphenol A exposure is involved in the development of Parkinson like disease in Drosophila melanogaster",
        "Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures",
        "Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity",
        "Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain",
        "Modulation of glutamate receptor functions by glutathione",
        "\u03b2-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease",
        "Measurement of oxidized/reduced glutathione ratio",
        "Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress",
        "Glutathione: a key player in autoimmunity",
        "Systemic activation of Nrf2 pathway in Parkinson's disease",
        "Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies",
        "Hepatic efflux and renal extraction of plasma glutathione: marked differences between healthy subjects and the rat",
        "Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases",
        "Manganism and Parkinson's disease: Mn(II) and Zn(II) interaction with a 30-amino acid fragment",
        "Homocysteine in neuropsychiatric disorders of the elderly",
        "Glutathione and mitochondria",
        "Randomized controlled trial of oral glutathione supplementation on body stores of glutathione",
        "Role of glutamate transporters in redox homeostasis of the brain",
        "Activators and inhibitors of NRF2: a review of their potential for clinical development",
        "The degeneration and replacement of dopamine cells in Parkinson's disease: the role of aging",
        "Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease",
        "Induction of Bcl-2 by functional regulation of G-protein coupled receptors protects from oxidative glutamate toxicity by increasing glutathione",
        "Farnesol quells oxidative stress, reactive gliosis and inflammation during acrylamide-induced neurotoxicity: behavioral and biochemical evidence",
        "An omega-class glutathione S-transferase in the brown planthopper Nilaparvata lugens exhibits glutathione transferase and dehydroascorbate reductase activities",
        "Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity",
        "Oxidative glutamate toxicity can be a component of the excitotoxicity cascade",
        "Curcumin affords neuroprotection and inhibits \u03b1-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model",
        "Synergistic versus antagonistic actions of glutamate and glutathione: the role of excitotoxicity and oxidative stress in neuronal disease",
        "Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia",
        "Glutathione-related enzymes in brain in Parkinson's disease",
        "The role of altered glutathione status in the development of Parkinson's disease",
        "Glutathione metabolism and Parkinson's disease",
        "Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease",
        "Chronic inflammation alters production and release of glutathione and related thiols in human U373 astroglial cells",
        "Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia",
        "Microglia and neuroinflammation: a pathological perspective",
        "Neuroprotective mechanisms of three natural antioxidants on a rat model of Parkinson's disease: a comparative study",
        "Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease",
        "Etiology and Pathogenesis of Parkinson's Disease, Movement Disorders Curricula",
        "Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain",
        "Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease",
        "Rotenone impairs oxidant/antioxidant balance both in brain and intestines in zebrafish",
        "Null genotype of GSTT1 contributes to increased Parkinson's disease risk in Caucasians: evidence from a meta-analysis",
        "Glutathione S-transferase M1 polymorphisms and Parkinson's disease risk: a meta-analysis",
        "Oxidative stress in Parkinson's disease: a systematic review and meta-analysis",
        "A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinson's disease susceptibility",
        "Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: a meta-analysis",
        "Redox remodeling as an immunoregulatory strategy",
        "Extracellular redox modulation by regulatory T cells",
        "Redox regulation of \u03b3-glutamyl transpeptidase"
    ],
    "affiliation": [
        {
            "affiliation-city": "Mo i Rana",
            "@id": "60158097",
            "affilname": "Council for Nutritional and Environmental Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60158097",
            "affiliation-country": "Norway"
        },
        {
            "affiliation-city": "Karaj",
            "@id": "60089309",
            "affilname": "Razi Vaccine &amp; Serum Research Institute, Iran",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60089309",
            "affiliation-country": "Iran"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Constanta",
            "@id": "60023386",
            "affilname": "Ovidius University of Constanta",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023386",
            "affiliation-country": "Romania"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sassari",
            "@id": "60010110",
            "affilname": "Universit\u00e0 degli Studi di Sassari",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010110",
            "affiliation-country": "Italy"
        }
    ],
    "funding": []
}